Weather Updates

How one little-known biotech incubator is changing the face of medicine

From left Sean Corrigan Insight Director Engineering Steve McPhilliamy Insight Partner/Director Design BriteSeed co-founder Paul Fehrenbacher during meeting Insight Product

From left, Sean Corrigan, Insight Director of Engineering, Steve McPhilliamy, Insight Partner/Director of Design, and BriteSeed co-founder Paul Fehrenbacher during a meeting at Insight Product Development in Chicago, Ill., on Thursday, March 21, 2013. | Andrew A. Nelles~Sun-Times Media

storyidforme: 46647508
tmspicid: 17285551
fileheaderid: 7789345

Updated: March 25, 2013 8:56AM

Paul A. Fehrenbacher and two fellow graduate students at Northwestern University are postponing their graduations to develop a technology to help surgeons identify and keep from accidentally cutting blood vessels.
Daniel Leventhal, a doctoral student in cancer biology at the University of Chicago, is helping advise two professors working to develop new ways of treating cancer with less radiation or by making radiation treatment more effective.
Both Fehrenbacher, 34, and Leventhal, 26, are benefitting from Chicago’s little-known biotech incubator, Chicago Innovation Mentors, or CIM, Sandra Guy writes at Grid.

© 2014 Sun-Times Media, LLC. All rights reserved. This material may not be copied or distributed without permission. For more information about reprints and permissions, visit To order a reprint of this article, click here.